BG61025B1 - Използване на хинони при лечение на рак или спин - Google Patents

Използване на хинони при лечение на рак или спин Download PDF

Info

Publication number
BG61025B1
BG61025B1 BG98041A BG9804193A BG61025B1 BG 61025 B1 BG61025 B1 BG 61025B1 BG 98041 A BG98041 A BG 98041A BG 9804193 A BG9804193 A BG 9804193A BG 61025 B1 BG61025 B1 BG 61025B1
Authority
BG
Bulgaria
Prior art keywords
composition according
acid
mol
quinone
composition
Prior art date
Application number
BG98041A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98041A (bg
Inventor
Washington O Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of BG98041A publication Critical patent/BG98041A/bg
Publication of BG61025B1 publication Critical patent/BG61025B1/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/15Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02Hydroxy-anthraquinones; Ethers or esters thereof
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG98041A 1991-02-13 1993-08-13 Използване на хинони при лечение на рак или спин BG61025B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use
PCT/GB1992/000262 WO1992014454A1 (en) 1991-02-13 1992-02-13 Use of quinones in the treatment of cancer or aids

Publications (2)

Publication Number Publication Date
BG98041A BG98041A (bg) 1994-05-27
BG61025B1 true BG61025B1 (bg) 1996-09-30

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98041A BG61025B1 (bg) 1991-02-13 1993-08-13 Използване на хинони при лечение на рак или спин

Country Status (30)

Country Link
EP (1) EP0499467A3 (lt)
JP (1) JPH06505231A (lt)
CN (1) CN1064407A (lt)
AP (1) AP549A (lt)
AU (2) AU1233992A (lt)
BG (1) BG61025B1 (lt)
BR (1) BR9205642A (lt)
CA (1) CA2104009A1 (lt)
CZ (1) CZ166893A3 (lt)
DZ (1) DZ1559A1 (lt)
FI (1) FI933595A0 (lt)
GB (2) GB9103075D0 (lt)
GT (1) GT199200009A (lt)
HU (1) HUT65634A (lt)
IE (1) IE920464A1 (lt)
IL (1) IL100906A (lt)
IN (1) IN178929B (lt)
IS (1) IS3814A (lt)
JO (1) JO1719B1 (lt)
LT (1) LT3197B (lt)
MA (1) MA22443A1 (lt)
MX (1) MX9200622A (lt)
MY (1) MY131098A (lt)
NO (1) NO932681L (lt)
NZ (2) NZ240487A (lt)
OA (2) OA09535A (lt)
SK (1) SK87993A3 (lt)
TN (1) TNSN92015A1 (lt)
WO (1) WO1992014454A1 (lt)
ZA (1) ZA921037B (lt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
EP0677292A1 (en) * 1994-03-17 1995-10-18 Radopath Limited Anti-viral and anti-cancer agents
EP0705601B1 (de) * 1994-10-04 2000-01-19 LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik Lösungen von Anthrachinonen zur parenteralen Applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US8092841B2 (en) 2007-08-08 2012-01-10 Bionovo, Inc. Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof
WO2009033075A1 (en) 2007-09-07 2009-03-12 Bionovo. Inc. ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF
WO2009033099A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of astragalus membranaceus fisch.bge.var.mongolicus bge. of the leguminosae family and uses thereof
JP2010538090A (ja) 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド ユリ科ファミリーのクサスギカズラのエストロゲン性抽出物およびその使用
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
EP2219659A4 (en) 2007-11-19 2010-11-17 Bionovo Inc METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
EP2222323A4 (en) 2007-11-19 2012-07-25 Bionovo Inc PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON
JP2011522822A (ja) * 2008-06-06 2011-08-04 バイオノボ・インコーポレーテッド エストロゲン受容体β媒介性病状の治療のためのダイオウ(Rheumpalmatum)由来のアントラキノンおよび類似体
WO2013055913A2 (en) * 2011-10-14 2013-04-18 Emory University Pgam1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
US20210309860A1 (en) * 2018-07-17 2021-10-07 Pili Anthraquinonic derivatives and their use as colouring agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
WO1989005141A1 (en) * 1987-12-10 1989-06-15 Tsumura Juntendo, Inc. Anti-retroviral drug
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
MC2246A1 (fr) * 1990-04-03 1993-03-25 Radopath Ltd Utilisation de trinitrobenzenes ou d'acide carminique dans le traitement du cancer ou des maladies virales
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
GT199200009A (es) 1993-08-06
GB2254554B (en) 1995-09-20
LT3197B (en) 1995-03-27
NZ241593A (en) 1995-05-26
DZ1559A1 (fr) 2002-02-17
IN178929B (lt) 1997-07-19
BR9205642A (pt) 1994-06-21
JO1719B1 (en) 1992-12-15
IS3814A (is) 1992-08-14
GB9103075D0 (en) 1991-03-27
IE920464A1 (en) 1992-08-12
NO932681D0 (no) 1993-07-26
AP549A (en) 1996-11-01
LTIP329A (en) 1994-08-25
FI933595A (fi) 1993-08-13
OA09535A (en) 1992-11-15
CZ166893A3 (en) 1994-03-16
IL100906A (en) 1996-09-12
GB2254554A (en) 1992-10-14
IL100906A0 (en) 1992-11-15
SK87993A3 (en) 1993-12-08
AU1233992A (en) 1992-09-15
WO1992014454A1 (en) 1992-09-03
NZ240487A (en) 1994-03-25
NO932681L (no) 1993-10-07
CN1064407A (zh) 1992-09-16
BG98041A (bg) 1994-05-27
HU9302347D0 (en) 1993-10-28
EP0499467A3 (en) 1992-12-16
EP0499467A2 (en) 1992-08-19
MX9200622A (es) 1992-11-01
HUT65634A (en) 1994-07-28
GB9203084D0 (en) 1992-03-25
FI933595A0 (fi) 1993-08-13
JPH06505231A (ja) 1994-06-16
MA22443A1 (fr) 1992-10-01
CA2104009A1 (en) 1992-08-14
AP9200356A0 (en) 1992-04-30
AU5590696A (en) 1996-08-08
OA09810A (en) 1994-04-15
ZA921037B (en) 1992-11-25
TNSN92015A1 (fr) 1993-06-08
MY131098A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
BG61025B1 (bg) Използване на хинони при лечение на рак или спин
Schultz Case study: high-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney
US6720011B1 (en) Injectable composition for cancer treatment
NL8501995A (nl) Werkwijze voor het remmen van acuut stralingssyndroom en het optreden van septiceem en daarvoor te gebruiken preparaat.
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
OA12862A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone.
US20080206736A1 (en) Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
Splinter et al. Phase I study of alpha-difluoromethylornithine and methyl-GAG
JP2020537689A (ja) A−ノル−5αアンドロスタン化合物を含む白血球増多製剤およびその使用
US7439234B2 (en) Method for treating cancer patients undergoing chemotherapy
US6169083B1 (en) Preventives/remedies for stomatitis
KR100514009B1 (ko) 1,2,4-벤조트리아진옥사이드제제
EP1210944A1 (en) Blood plasma replacement solution
US20100016244A1 (en) D-glucopyranose 1-[3,5-bis (1,1-dimethylethy)-4-hydroxybenzoate] and its derivatives, preparation and use thereof
CN111803482B (zh) 鹿茸单体在制备抑制乳腺肿瘤骨转移的药物中的应用及药物
JPH01313433A (ja) 抗hiv剤
EP1203585B1 (en) Anti-ischemic agent
Clifford et al. Dimethyl myleran therapy combined with abdominal aortic occlusion
CA2193838A1 (en) Disease preventive/remedy
RU2026679C1 (ru) Способ противоопухолевой терапии при первичном раке печени
KR20020026743A (ko) 비소화합물 및 글루타치온 고갈 유도 화합물을 함유하는항암조성물
HU179753B (en) Process for producting synergetic pharmaceutical compositions of citostatic activity
US20020123480A1 (en) Methods and compositions utilizing 2&#39;-5&#39; oligoadenylates in the treatment of disorders of cell proliferation